Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051051
Status:
COMPLETED
Last Update Posted:
2007-05-04
First Post:
2003-01-02
Brief Title:
A Phase II Study of CI-1033 in Treating Patients With Metastatic Stage IV Breast Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Neoplasms |
Keywords: